146 related articles for article (PubMed ID: 21882108)
21. [Better medicines for children].
Brasseur D
Rev Med Brux; 2006; 27 Spec No():Sp25-8. PubMed ID: 21818889
[TBL] [Abstract][Full Text] [Related]
22. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
23. Who are the PDCO?
Dempsey EM; Connolly K
Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
[TBL] [Abstract][Full Text] [Related]
24. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
Rocchi F; Tomasi P
Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
[TBL] [Abstract][Full Text] [Related]
25. New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better?
Garazzino S; Lutsar I; Bertaina C; Tovo PA; Sharland M
Int J Antimicrob Agents; 2013 Aug; 42(2):99-118. PubMed ID: 23810180
[TBL] [Abstract][Full Text] [Related]
26. EU law mandates drug testing in children.
Sinha G
J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
[No Abstract] [Full Text] [Related]
27. Basics and dynamics of neonatal and pediatric pharmacology.
Seyberth HW; Kauffman RE
Handb Exp Pharmacol; 2011; 205():3-49. PubMed ID: 21882104
[TBL] [Abstract][Full Text] [Related]
28. Uses of drugs not described in the package insert (off-label uses).
Committee on Drugs. American Academy of Pediatrics
Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
[TBL] [Abstract][Full Text] [Related]
29. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
30. Impact of the European paediatric legislation in paediatric rheumatology: past, present and future.
Ruperto N; Vesely R; Saint-Raymond A; Martini A;
Ann Rheum Dis; 2013 Dec; 72(12):1893-6. PubMed ID: 23962457
[TBL] [Abstract][Full Text] [Related]
31. Better medicines for children--where are we now, and where do we want to be?
Rose K
Br J Clin Pharmacol; 2005 Jun; 59(6):657-9. PubMed ID: 15948927
[No Abstract] [Full Text] [Related]
32. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
33. [Drugs in Europe].
Bouzy C; Abadie E
Rev Prat; 2002 Mar; 52(5):510-4. PubMed ID: 11949504
[TBL] [Abstract][Full Text] [Related]
34. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.
Jacqz-Aigrain E
Early Hum Dev; 2011 Mar; 87 Suppl 1():S27-30. PubMed ID: 21269785
[TBL] [Abstract][Full Text] [Related]
35. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
Ekimoto H
Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
[TBL] [Abstract][Full Text] [Related]
36. Off-label use of drugs in children.
Frattarelli DA; Galinkin JL; Green TP; Johnson TD; Neville KA; Paul IM; Van Den Anker JN;
Pediatrics; 2014 Mar; 133(3):563-7. PubMed ID: 24567009
[TBL] [Abstract][Full Text] [Related]
37. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
38. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
39. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
Matthews JH
Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
[TBL] [Abstract][Full Text] [Related]
40. [Drug evaluation: new requirements and perspectives].
Addis A; Rocchi F
Recenti Prog Med; 2006 Nov; 97(11):618-25. PubMed ID: 17252718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
